Eq5Dmap: A Command for Mapping between EQ-5D-3L and EQ-5D-5L [PDF]
In this article, we describe a new command, eq5dmap, for conditional prediction of the utility values of EQ-5D-5L (EQ-5D-3L) from observed or specified values of EQ-5D-3L (EQ-5D-5L) conditional on age and gender. Predictions can be made either from the five-item health descriptions or from the (exact or approximate) utility score.
Hernandez, M., Pudney, S.
openaire +2 more sources
An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness Analysis [PDF]
To estimate the impact of using EQ5D-5L (5L) compared with EQ5D-3L (3L) in cost-effectiveness analyses in 6 countries with 3L and 5L values: Germany, Japan, Korea, The Netherlands, China, and Spain.Eight cost-effectiveness analyses based on clinical studies with 3L provided 11 pairwise comparisons.
Wailoo, A. +8 more
openaire +7 more sources
Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease [PDF]
The official published version of the article can be found at the link below.Background: The EuroQoL 5D (EQ-5D) is a questionnaire that provides a measure of utility for cost-effectiveness analysis.
Dyer, Matthew T. +19 more
core +3 more sources
Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter? [PDF]
The EQ-5D and Short Form (SF)12 are widely used generic health-related quality of life (HRQoL) questionnaires. They can be used to derive health utility index scores, on a scale where 0 is equivalent to death and 1 represents full health, with scores ...
Serpell, MG +16 more
core +1 more source
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease [PDF]
The EuroQol five-dimension questionnaire (EQ-5D) is the most commonly used instrument to obtain utility values for cost-effectiveness analyses of treatments for Crohn's disease (CD). We aimed to compare the measurement properties of the two adult versions of EQ-5D (EQ-5D-3L and EQ-5D-5L) in patients with CD.Between 2016 and 2017, a multicentre cross ...
Fanni Rencz +11 more
openaire +3 more sources
Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany [PDF]
Eidt-Koch D, Mittendorf T, Greiner W. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. BMC Pediatrics. 2009;9(1):55.Background: Quality of life is recognized as an
Greiner, Wolfgang +8 more
core +2 more sources
Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets [PDF]
Quality-adjusted life-years are the common outcome measure in contemporary economic evaluations in health care. Due to the limitations of the sensitivity of the EQ-5D-3L in specific disease conditions, the EuroQoL group has developed a new EQ-5D-5L classification system with 3,125 health states.
Kularatna, Sanjeewa +3 more
openaire +5 more sources
A review of health utilities using the EQ-5D in studies of cardiovascular disease [PDF]
Background The EQ-5D has been extensively used to assess patient utility in trials of new treatments within the cardiovascular field. The aims of this study were to review evidence of the validity and reliability of the EQ-5D, and to summarise utility ...
Buxton, Martin J +17 more
core +4 more sources
Response‐Scale Heterogeneity in the EQ‐5D [PDF]
AbstractThis paper discusses two types of response‐scale heterogeneity, which may impact upon the EQ‐5D. Response‐scale heterogeneity in reporting occurs when individuals systematically differ in their use of response scales when responding to self‐assessments.
Knott, Rachel J. +3 more
openaire +3 more sources
Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions [PDF]
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work ...
Buxton, Martin J +15 more
core +6 more sources

